Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters

被引:0
|
作者
Ali Azizi
David E Anderson
Masoud Ghorbani
Katrina Gee
Francisco Diaz-Mitoma
机构
[1] Research Institute Children's Hospital of Eastern Ontario,Infectious Disease and Vaccine Research Centre
[2] Variation Biotechnologies Inc.,Center for Neurologic Diseases, Brigham and Women's Hospital
[3] Harvard Medical School,undefined
来源
BMC Immunology | / 7卷
关键词
Gp120 Protein; Neutralize Antibody Response; Nabs Titre; Polyvalent Vaccine; Recombinant Gp120 Protein;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Immunogenicity of a polyvalent HIV-1 candidate vaccine based on fourteen wild type gp120 proteins in golden hamsters
    Azizi, Ali
    Anderson, David E.
    Ghorbani, Masoud
    Gee, Katrina
    Diaz-Mitoma, Francisco
    BMC IMMUNOLOGY, 2006, 7 (1)
  • [2] Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120
    Fouts, TR
    Tuskan, RG
    Chada, S
    Hone, DM
    Lewis, GK
    VACCINE, 1995, 13 (17) : 1697 - 1705
  • [3] LYMPHOPROLIFERATIVE RESPONSES TO A CANDIDATE HIV-1 GP120 SUBUNIT VACCINE IN HUMAN VOLUNTEERS
    BAENZIGER, J
    SINANGIL, F
    REECE, J
    SAKAMOTO, D
    RODDA, S
    KAHN, J
    CHERNOFF, D
    DEKKER, C
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 78 - 78
  • [4] HIV-1 gp120: A Target for Therapeutics and Vaccine Design
    Cicala, Claudia
    Nawaz, Fatima
    Jelicic, Katija
    Arthos, James
    Fauci, Anthony S.
    CURRENT DRUG TARGETS, 2016, 17 (01) : 122 - 135
  • [5] Factors limiting the immunogenicity of HIV-1 gp120 envelope glycoproteins
    Grundner, C
    Pancera, M
    Kang, JM
    Koch, M
    Sodroski, J
    Wyatt, R
    VIROLOGY, 2004, 330 (01) : 233 - 248
  • [6] Immunogenicity of the outer domain of a HIV-1 clade C gp120
    Hongying Chen
    Xiaodong Xu
    Ian M Jones
    Retrovirology, 4
  • [7] Immunogenicity of the outer domain of a HIV-1 clade C gp120
    Chen, Hongying
    Xu, Xiaodong
    Jones, Ian M.
    RETROVIROLOGY, 2007, 4 (1)
  • [8] Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine
    McFarland, EJ
    Borkowsky, W
    Fenton, T
    Wara, D
    McNamara, J
    Samson, P
    Kang, MH
    Mofenson, L
    Cunningham, C
    Duliege, AM
    Sinangil, F
    Spector, SA
    Jimenez, E
    Bryson, Y
    Burchett, S
    Frenkel, LM
    Yogev, R
    Gigliotti, F
    Luzuriaga, K
    Livingston, RA
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10): : 1331 - 1335
  • [9] Optimization of the Outer Domain of gp120 as an HIV-1 Vaccine Immunogen
    Xu, L.
    Boyington, J. C.
    Zhou, T.
    Zhu, J.
    Wu, L.
    Louder, M. K.
    Akahata, W.
    Kwong, P. D.
    Mascola, J. R.
    Yang, Z.
    Nabel, G. J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A166 - A167
  • [10] Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum
    Bansal, AK
    Mactutus, CF
    Nath, A
    Maragos, W
    Hauser, KF
    Booze, RM
    BRAIN RESEARCH, 2000, 879 (1-2) : 42 - 49